The David H. Koch Institute for Integrative Cancer Research at MIT both transforms and transcends the MIT Center for Cancer Research (CCR). Founded in 1974 by Nobel Laureate and MIT Professor Salvador Luria, CCR has made enormous contributions to the field of cancer research, including: identified the molecules that led to two of the first FDA-approved molecularly targeted anti-cancer drugs, Herceptin? (1998) and Gleevec? (2001); isolated the first human cancer genes; discovered extracellular matrix components and their receptors, which play a critical role in metastasis; contributed to the sequencing of the human genome; and developed novel materials for sustained delivery of anti-cancer drugs.

CCR/Koch remains one of only eight National Cancer Institute-designated basic research centers in the US. And our faculty have earned the most prestigious national and international science honors: five current and former faculty have been awarded the Nobel Prize; 14 current faculty are members of the National Academy of Sciences; 6 current and former faculty have been awarded the National Medal of Science; 5 current faculty are Howard Hughes Medical Institute Investigators.

Note: The MIT Center for Cancer Research (CCR) changed its name to the David H. Koch Institute for Integrative Cancer Research at MIT (Koch Institute) effective March 2008. This name change is linked to generous funding received in support of the creation of a new building and endeavor, to be completed by the year 2010, to house expanded and innovative cancer research at MIT.

© 2012 AcademicJobsOnline.Org. All Rights Reserved.